Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K /Akt/ mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study
Cancer Reports · 2025-05 · 8 (5)
DOI: 10.1002/cnr2.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 10.05.2025. Verfasst von Junli Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Third People's Hospital of Bengbu Affiliated to Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Quercetin, Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Project of Natural Science Research Project of Colleges and Universities in Anhui Province, the Program for Science and Technology Research of Bengbu Medical College, Open Project of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment.
Abstract (Originalsprache)
Background
Quercetin is a natural product with multiple activities, which possesses a promising antitumor effect on malignancies. The involvement of proline 4‐hydroxylase II (P4HA2) in collagen synthesis is crucial in the growth of tumor cells. Apoptosis is a programmed cell death requisite for the stability of the intracellular environment. However, the relationship between quercetin and cell apoptosis, as well as the impact of P4HA2 in this connection, has not yet been specified in hepatocellular carcinoma(HCC).
Aims
The present study used HCC cells to investigate how quercetin regulates P4HA2 and influences cell proliferation and apoptosis. Methods and Results The outcomes reveal that quercetin can impede the viability and growth of HCC cells and generate cell apoptosis in a dose‐dependent manner. Additionally, quercetin prompts downregulation of P4HA2, leading to cell apoptosis in HCC cells, and knocking down P4HA2 can enhance this effect. Furthermore, we pretreated HCC cells with inhibitors (Z‐VAD‐FMK, LY294002) or activators (740Y‐P) and found that the PI3K/Akt/mTOR pathway was occupied with quercetin‐induced cell apoptosis.
Conclusion
This investigation reveals that quercetin compels apoptosis in HCC cells by diminishing P4HA2 and restraining the PI3K/Akt/mTOR axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third People's Hospital of Bengbu Affiliated to Bengbu Medical University, Bengbu, China.
- Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu, China.
- Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, Bengbu Medical University, Bengbu, China.
- Department of Biochemistry and Molecular Biology, School of Laboratory Medicine, Bengbu Medical University, Bengbu, China.
ORCID-Profile: Wenjuan Wu
Förderung
- the Key Project of Natural Science Research Project of Colleges and Universities in Anhui Province
- the Program for Science and Technology Research of Bengbu Medical College
- Open Project of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment
Zitieren
APA
Zhang, J., Guo, J., Qian, Y., Yu, L., Ma, J., Gu, B., Tang, W., Li, Y., Li, H., & Wu, W. (2025). Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K /Akt/ mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study. Cancer Reports, 8(5). https://doi.org/10.1002/cnr2.70220
Vancouver
Zhang J, Guo J, Qian Y, Yu L, Ma J, Gu B, et al. Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K /Akt/ mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study. Cancer Reports. 2025;8(5). doi:10.1002/cnr2.70220
BibTeX
@article{Zhang2025,
author = {Zhang, Junli and Guo, Jiayi and Qian, Ying and Yu, Lianchen and Ma, Junrao and Gu, Biao and Tang, Weichun and Li, Yi and Li, Hongwei and Wu, Wenjuan},
title = {Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K /Akt/ mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study},
journal = {Cancer Reports},
year = {2025},
volume = {8},
number = {5},
doi = {10.1002/cnr2.70220}
}
EUVIMED